{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:26:16Z","timestamp":1787840776261,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hepatitis B virus is one of the transfusion transmissible infections. Despite the availability of hepatitis B virus (HBV) vaccine and screening tests but still danger of virus transmission via blood transfusion is high in some regions. The objective of this study was to determine the trend of seroprevalence of hepatitis B in over an 11-year period (2005\u20132015).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this study, 355,083 blood donors were estimated for hepatitis B surface antigen (HBs Ag) seropositivity during 2005\u20132015 who referred to blood infusion centers of Lorestan province. Third-generation ELISA method was used to detect HBs Ag.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The prevalence of HBs Ag in blood donors was 0.29% (1017). It was decreased steadily from 2005 to 2015 (0.68% to 0.12%) but increased in 2008 year. The trend prevalence of HBs Ag seropositivity significantly decreased over the study period (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The decline in HBV infection rates was more prominent in regular and repeated donor's groups compared to people who donated blood for the first time (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The result of present study was indicated, Lorestan city in west of Iran can be classified as a low-income region because the low prevalence of HBs Ag in blood donors. Also the prevalence of HBs Ag in first-time donors was higher than other groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpvm.ijpvm_260_18","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T08:42:26Z","timestamp":1716885746000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Trend in Prevalence of Hepatitis B Virus Infection Among Blood Donor Individuals: An Eleven-year of Experience in Lorestan, Iran"],"prefix":"10.4103","volume":"11","author":[{"given":"Abbas Ahmadi","family":"Vasmehjani","sequence":"first","affiliation":[{"name":"Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Yaghubi","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Iranshahr University of Medical Sciences, Iranshahr, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Erfani","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Teshran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zamaneh","family":"Hajikhezri","sequence":"additional","affiliation":[{"name":"Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Farahmand","sequence":"additional","affiliation":[{"name":"Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shayestehpour","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran"},{"name":"Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid Ali","family":"Adeli","sequence":"additional","affiliation":[{"name":"Department of Public Health, Lorestan University of Medical Sciences, Khoramabad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Beiranvand","sequence":"additional","affiliation":[{"name":"Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran"},{"name":"Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Khoramabad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4254\/wjh.v3.i12.292","article-title":"Management of hepatitis B in developing countries","volume":"3","author":"Abbas","year":"2011","journal-title":"World J Hepatol"},{"key":"R2-20250812","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jhep.2009.05.020","article-title":"Transfusion-transmitted hepatitis B virus infection","volume":"51","author":"Candotti","year":"2009","journal-title":"J Hepatol"},{"key":"R3-20250812","first-page":"24","article-title":"Increased the specificity and sensitivity of monospecific antibody against host cell protein (HCP) in quality control of hepatitis B recombinant vaccine","volume":"2","author":"Hosseini","year":"2011","journal-title":"J Paramed Sci"},{"key":"R4-20250812","first-page":"187","article-title":"Global Epidemiology of Hepatitis B Virus Infection. Hepatitis B Virus in Human Diseases","author":"Lavanchy","year":"2016","journal-title":"Springer"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0264-410X(99)00456-9","article-title":"Hepatitis B epidemiology in Asia, the middle East and Africa","volume":"18","author":"Andr\u00e9","year":"2000","journal-title":"Vaccine"},{"key":"R6-20250812","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"R8-20250812","first-page":"225","article-title":"The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: A population-based study","volume":"12","author":"Merat","year":"2009","journal-title":"Arch Iran Med"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"290","DOI":"10.26719\/1996.2.2.290","article-title":"Epidemiology of hepatitis B in the Islamic Republic of Iran","volume":"2","author":"Zali","year":"1996","journal-title":"East Mediterr Health J"},{"key":"R10-20250812","doi-asserted-by":"crossref","first-page":"e35577","DOI":"10.5812\/hepatmon.35577","article-title":"Hepatitis B virus infection in the general population of Iran: An updated systematic review and meta-analysis","volume":"16","author":"Salehi-Vaziri","year":"2016","journal-title":"Hepat Mon"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5812\/kowsar.1735143X.1965","article-title":"Hepatitis C and hepatitis B virus infection: Epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran","volume":"11","author":"Mohebbi","year":"2011","journal-title":"Hepat Mon"},{"key":"R12-20250812","first-page":"842","article-title":"The prevalence rate of human immunodeficiency virus co-infection in HBV and HCV positive patients in Lorestan province: A single referral center experience","volume":"8","author":"Nazer","year":"2017","journal-title":"Int J Adv Biotechnol Res"},{"key":"R13-20250812","first-page":"e00373","article-title":"Prevalence of HIV, HBV, and HCV and related risk factors amongst male homeless people in Lorestan province, the west of Iran","volume":"17","author":"Doosti-Irani","year":"2017","journal-title":"J Res Health Sci"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1743-422X-8-96","article-title":"Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009","volume":"8","author":"Durro","year":"2011","journal-title":"Virol J"},{"key":"R15-20250812","doi-asserted-by":"crossref","first-page":"e0157615","DOI":"10.1371\/journal.pone.0157615","article-title":"Prevalence and trends of transfusion-Transmissible viral infections among blood donors in south of Iran: An Eleven-Year retrospective study","volume":"11","author":"Farshadpour","year":"2016","journal-title":"PloS One"},{"key":"R16-20250812","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/cid\/ciq247","article-title":"Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection","volume":"52","author":"Yuen","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R17-20250812","first-page":"51","article-title":"Hepatitis B virus infection in Iran; Changing the epidemiology","volume":"5","author":"Alavian","year":"2010","journal-title":"Arch Clin Infec Dis"},{"key":"R18-20250812","doi-asserted-by":"crossref","first-page":"e35664","DOI":"10.5812\/hepatmon.35664","article-title":"The HBsAg prevalence among blood donors from Eastern Mediterranean and Middle Eastern countries: A systematic review and meta-Analysis","volume":"16","author":"Babanejad","year":"2016","journal-title":"Hepat Mon"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/j.1537-2995.2009.02245.x","article-title":"Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007","volume":"49","author":"Amini Kafi-abad","year":"2009","journal-title":"Transfusion"},{"key":"R20-20250812","first-page":"613","article-title":"Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005-2011","volume":"17","author":"Mohammadali","year":"2014","journal-title":"Arch Iran Med"},{"key":"R21-20250812","first-page":"4","article-title":"Prevalence of HIV, hepatitis B and C infections among volunteer blood donors at the blood transfusion center of Ilam city, Iran","volume":"4","author":"Boustani","year":"2017","journal-title":"J Basic Res Med Sci"},{"key":"R22-20250812","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-3148.2009.00935.x","article-title":"Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007","volume":"19","author":"Kafi-Abad","year":"2009","journal-title":"Transfus Med"},{"key":"R23-20250812","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/jjm.46152","article-title":"Hepatitis B, hepatitis C, and human immunodeficiency virus infection in multi-transfused thalassemic patients, Kermanshah, Iran, 2015","volume":"10","author":"Sayad","year":"2017","journal-title":"Jundishapur J Microbiol"},{"key":"R24-20250812","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1423-0410.1979.tb02289.x","article-title":"The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran","volume":"37","author":"Farzadegan","year":"1979","journal-title":"Vox Sang"},{"key":"R25-20250812","doi-asserted-by":"crossref","first-page":"e25028","DOI":"10.5812\/ijhrba.25028","article-title":"Prevalence of HCV infections and co-infection with HBV and HIV and associated risk factors among addicts in Drug Treatment Centers, Lorestan Province, Iran","volume":"5","author":"Norouzian","year":"2016","journal-title":"Int J High Risk Behav Addict"},{"key":"R26-20250812","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2334-10-111","article-title":"Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: Declining trends over a period of five years","volume":"10","author":"Tessema","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R27-20250812","first-page":"359","article-title":"Comparison of positive HBsAg prevalence in first-time, repeat, and regular blood donors for the purpose of selecting donors in Hamedan Blood Transfusion Center","volume":"4","author":"Ranjbarian","year":"2008","journal-title":"Sci J Blood Transfus Organ"},{"key":"R28-20250812","first-page":"249","article-title":"Prevalence of chronic hepatitis B infection in Iran: A review article","volume":"14","author":"Poorolajal","year":"2009","journal-title":"J Res Med Sci"},{"key":"R29-20250812","first-page":"301","article-title":"A comparison of seroprevalence of blood-borne infections among regular, sporadic, and first-time blood donors in Isfahan","volume":"2","author":"Masaeli","year":"2006","journal-title":"Sci J Blood Transfus Org"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_260_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:28:45Z","timestamp":1787837325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_260_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_260_18","relation":{},"ISSN":["2008-7802","2008-8213"],"issn-type":[{"value":"2008-7802","type":"print"},{"value":"2008-8213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"2018-05-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}